Skip to main content
Top
Published in: Journal of Clinical Immunology 5/2015

01-07-2015 | Astute Clinician Report

Disseminated Mycobacterium avium Complex Infection in a Child with Partial Dominant Interferon Gamma Receptor 1 Deficiency in India

Authors: Varun K. Sharma, Gautham Pai, Caroline Deswarte, Rakesh Lodha, Sarman Singh, Liew Woei Kang, Chong Chia Yin, Jean-Laurent Casanova, Jacinta Bustamante, Sushil K. Kabra

Published in: Journal of Clinical Immunology | Issue 5/2015

Login to get access

Abstract

Mendelian susceptibility to mycobacterial disease (MSMD) is a rare condition characterized by clinical disease caused by weakly virulent mycobacteria. All genes mutated in MSMD patients are involved in IFN-γ immunity. Autosomal partial dominant (PD) interferon-γ receptor 1 (IFN-γR1) deficiency is the most frequent abnormality affecting the group of MSMD patients leading to impaired response of IFN-γ. We describe here a patient from India with disseminated infection due to Mycobacterium avium intracellulare (MAC) including multifocal osteomyelitis and BCG disease. A heterozygous mutation in exon 6 of IFNGR1 gene was identified, conferring an autosomal PD IFN-γR1 deficiency. Patient had recurrence of mycobacterial disease during antibiotic therapy for which subcutaneous IFN-γ was added as a modality of treatment for resistant MAC infection.
Literature
1.
go back to reference Al-Muhsen S, Casanova JL. The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases. J Allerg Clin Immunol. 2008;122(6):1043–51.CrossRef Al-Muhsen S, Casanova JL. The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases. J Allerg Clin Immunol. 2008;122(6):1043–51.CrossRef
2.
go back to reference Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological and clinical features of inborn errors of IFN-g immunity. Semin Immunol. 2014, in press. Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological and clinical features of inborn errors of IFN-g immunity. Semin Immunol. 2014, in press.
3.
go back to reference Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335:1941–9.PubMedCrossRef Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335:1941–9.PubMedCrossRef
4.
go back to reference Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacilleCalmette-Guérin infection. N Engl J Med. 1996;335(26):1956–61.PubMedCrossRef Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacilleCalmette-Guérin infection. N Engl J Med. 1996;335(26):1956–61.PubMedCrossRef
5.
go back to reference Gupta S, Madkaikar M, Singh S, Sehgal S. Primary immunodeficiencies in India: a perspective. Ann N Y Acad Sci. 2012;1250:73–9.PubMedCrossRef Gupta S, Madkaikar M, Singh S, Sehgal S. Primary immunodeficiencies in India: a perspective. Ann N Y Acad Sci. 2012;1250:73–9.PubMedCrossRef
6.
go back to reference Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Casanova JL, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet. 1999;21(4):370–8.PubMedCrossRef Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Casanova JL, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet. 1999;21(4):370–8.PubMedCrossRef
7.
go back to reference Sologuren I, Boisson-Dupuis S, Pestano J, Vincent QB, Fernández-Pérez L, et al. Partial recessive IFN-γR1 deficiency, genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum Mol Genet. 2011;20(8):1509–23.PubMedCentralPubMedCrossRef Sologuren I, Boisson-Dupuis S, Pestano J, Vincent QB, Fernández-Pérez L, et al. Partial recessive IFN-γR1 deficiency, genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum Mol Genet. 2011;20(8):1509–23.PubMedCentralPubMedCrossRef
8.
go back to reference Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon gamma receptor 1deficiencies. Lancet. 2004;364(9451):2113–21.PubMedCrossRef Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon gamma receptor 1deficiencies. Lancet. 2004;364(9451):2113–21.PubMedCrossRef
9.
go back to reference Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A Preliminary Rep N Engl J Med. 1994;330:1348–55.CrossRef Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A Preliminary Rep N Engl J Med. 1994;330:1348–55.CrossRef
10.
go back to reference Alangari AA, Al-Zamil F, Al-Mazrou A, Al-Muhsen S, Boisson-Dupuis S, Awadallah S, et al. Treatment of disseminated mycobacterial infection with high-dose IFN-γ in a patient with IL-12Rβ1 deficiency. Clin Dev Immunol. 2011;2011:691956.PubMedCentralPubMedCrossRef Alangari AA, Al-Zamil F, Al-Mazrou A, Al-Muhsen S, Boisson-Dupuis S, Awadallah S, et al. Treatment of disseminated mycobacterial infection with high-dose IFN-γ in a patient with IL-12Rβ1 deficiency. Clin Dev Immunol. 2011;2011:691956.PubMedCentralPubMedCrossRef
11.
go back to reference Takeda K, Kawai T, Nakazawa Y, Komuro H, Shoji K, Morita K, et al. Augmentation of antitubercular therapy with IFNγ in a patient with dominant partial IFNγ receptor 1 deficiency. Clin Immunol. 2014;151(1):25–8.PubMedCrossRef Takeda K, Kawai T, Nakazawa Y, Komuro H, Shoji K, Morita K, et al. Augmentation of antitubercular therapy with IFNγ in a patient with dominant partial IFNγ receptor 1 deficiency. Clin Immunol. 2014;151(1):25–8.PubMedCrossRef
Metadata
Title
Disseminated Mycobacterium avium Complex Infection in a Child with Partial Dominant Interferon Gamma Receptor 1 Deficiency in India
Authors
Varun K. Sharma
Gautham Pai
Caroline Deswarte
Rakesh Lodha
Sarman Singh
Liew Woei Kang
Chong Chia Yin
Jean-Laurent Casanova
Jacinta Bustamante
Sushil K. Kabra
Publication date
01-07-2015
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 5/2015
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-015-0173-1

Other articles of this Issue 5/2015

Journal of Clinical Immunology 5/2015 Go to the issue